163 related articles for article (PubMed ID: 30106137)
1. Gene regulatory network construction identified NFYA as a diffuse subtype-specific prognostic factor in gastric cancer.
Cao B; Zhao Y; Zhang Z; Li H; Xing J; Guo S; Qiu X; Zhang S; Min L; Zhu S
Int J Oncol; 2018 Nov; 53(5):1857-1868. PubMed ID: 30106137
[TBL] [Abstract][Full Text] [Related]
2. Gene regulatory pattern analysis reveals essential role of core transcriptional factors' activation in triple-negative breast cancer.
Min L; Zhang C; Qu L; Huang J; Jiang L; Liu J; Pinello L; Yuan GC; Shou C
Oncotarget; 2017 Mar; 8(13):21938-21953. PubMed ID: 28423538
[TBL] [Abstract][Full Text] [Related]
3. Construction of disease-specific transcriptional regulatory networks identifies co-activation of four gene in esophageal squamous cell carcinoma.
Zhao Y; Min L; Xu C; Shao L; Guo S; Cheng R; Xing J; Zhu S; Zhang S
Oncol Rep; 2017 Jul; 38(1):411-417. PubMed ID: 28560409
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
Pan HX; Bai HS; Guo Y; Cheng ZY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
[TBL] [Abstract][Full Text] [Related]
5. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
[TBL] [Abstract][Full Text] [Related]
6. Identifying novel biomarkers of gastric cancer through integration analysis of single nucleotide polymorphisms and gene expression profile.
Wang T; Xu Y; Hou P
Int J Biol Markers; 2015 Jul; 30(3):e321-6. PubMed ID: 25982683
[TBL] [Abstract][Full Text] [Related]
7. Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer.
Kim SK; Kim HJ; Park JL; Heo H; Kim SY; Lee SI; Song KS; Kim WH; Kim YS
Gastric Cancer; 2020 May; 23(3):473-482. PubMed ID: 31773340
[TBL] [Abstract][Full Text] [Related]
8. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
9. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.
Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474
[TBL] [Abstract][Full Text] [Related]
10. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
11. Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
Sun T; Wang D; Ping Y; Sang Y; Dai Y; Wang Y; Liu Z; Duan X; Tao Z; Liu W
Int J Oncol; 2020 Feb; 56(2):460-469. PubMed ID: 31894266
[TBL] [Abstract][Full Text] [Related]
12. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
[TBL] [Abstract][Full Text] [Related]
13. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
Ren C; Chen H; Han C; Fu D; Wang D; Shen M
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor NF‑YA promotes a malignant phenotype by upregulating fatty acid synthase expression.
Guo J; Kong LM; Peng AF; Long XH; Zhou Y; Shu Y
Mol Med Rep; 2016 Dec; 14(6):5007-5014. PubMed ID: 27840951
[TBL] [Abstract][Full Text] [Related]
15. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
16. Integrated microRNA network analyses identify a poor-prognosis subtype of gastric cancer characterized by the miR-200 family.
Song F; Yang D; Liu B; Guo Y; Zheng H; Li L; Wang T; Yu J; Zhao Y; Niu R; Liang H; Winkler H; Zhang W; Hao X; Chen K
Clin Cancer Res; 2014 Feb; 20(4):878-89. PubMed ID: 24352645
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of sorting nexin 10 weak expression in stomach adenocarcinoma revealed by weighted gene co-expression network analysis.
Zhang J; Wu Y; Jin HY; Guo S; Dong Z; Zheng ZC; Wang Y; Zhao Y
World J Gastroenterol; 2018 Nov; 24(43):4906-4919. PubMed ID: 30487700
[TBL] [Abstract][Full Text] [Related]
18. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression.
Zhang J; Liu H; Hou L; Wang G; Zhang R; Huang Y; Chen X; Zhu J
Mol Cancer; 2017 Sep; 16(1):151. PubMed ID: 28893265
[TBL] [Abstract][Full Text] [Related]
20. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
